Cygnus Capital Advisors »

Allogene Therapeutics shares owned by Cygnus Capital Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Cygnus Capital Advisors from 13F filings

Historical chart of Cygnus Capital Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Cygnus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Cygnus Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.0k 3.2k 2.47
2025-12-31 $4.0k 3.2k 1.24

More positions owned by Cygnus Capital Advisors

Husqvarna Ab sn (HUSQF)
Novo-Nordisk A-S Ord (NONOF)
Target Corporation (TGT)
Advance Auto Parts (AAP)
United Parcel Service (UPS)
Kyndryl Holdings Ord Wi (KD)
Sma Solar Technology
Pfizer (PFE)
Nine Energy Service
Adobe Systems Incorporated (ADBE)
Versant Media Group (VSNT)
Tripadvisor (TRIP)
Workday Inc cl a (WDAY)
easyJet
Ww Intl (WW)

View all positions for Cygnus Capital Advisors

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Millennium Management
Candriam Luxembourg S.C.A.
Wildcat Capital Management

View all funds holding Allogene Therapeutics